Additionally, each autoantibody was associated with unique clinical characteristics, with anti‐CD209 IgM being more common in patients with CAD, anti‐CD209L IgM present exclusively in males, and anti‐ACE2 IgM and anti‐IFNα IgG associated with more severe disease. This evidence concerns the gene IFNA1 and coronary artery disorder.